The weekly litigation news digest is live. Subscribe now

IP Verse

Impax Laboratories competitive analysis

Loading summary...

Latest patents of Impax Laboratories opposed by its competitors

Explore Impax Laboratories's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Nov 13, 2025
Patent NumberPublication DateTitleTotal Oppositions
EP3054929
Aug 5, 2020Muco-Adhesive, Controlled Release Formulations Of Levodopa And/Or Esters Of Levodopa And Uses Thereof1
EP2234963
Apr 8, 2020Controlled Release Formulations Of Levodopa And Uses Thereof2
EP3068396
May 8, 2019Rapidly Disintegrating Formulations And Methods Of Use1

Latest PTAB cases involving Impax Laboratories

Discover the latest PTAB cases involving Impax Laboratories, highlighting their recent legal challenges and patent disputes.

Last updated on: Nov 17, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Impax Laboratories

IPR2014-00731May 7, 2014IMPAX LABORATORIESMEDA PHARMACEUTICALSInstitution Denied

Peer Comparison New

IP litigation analysis comparing Impax Laboratories with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 13, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
IMPAX LABORATORIES - 41 -
LEDERER & KELLER PATENTANWALTE PARTNERSCHAFT MBB17 - - -
LUIGI16 - - -
MEDA PHARMACEUTICALS - - - 1